MaxCyte Reports Mixed Q1 2026 Results Revenue Dips While Expenses Decline Trumps Tariff Strategy Maintaining Policy Focus Despite Recent Court Setbacks New Report Urges Major Boost to Manufacturing USA Program and National Industrial Strategy